DIRS.INFO The most relevant business & tech news

HONG KONG, March 8 (Reuters) - China has announced plans for a national data bureau, describing it as part of an effort to coordinate data resources in the country and to achieve a vision of "digital China" conceived by President Xi Jinping. Xi's vision for a "digital China" aims to see the country populated by smart, internet-connected cities and data treated alongside labour and capital as a key factor to drive the economy and help China compete more effectively globally. In December, China's top leadership published an outline of how China should develop basic data systems and utilize the country's data resources. Last week, they unveiled a new plan that aims for the country to lead digital development globally by 2035. Areas to watch include big data infrastructure, data processing, the digitization of government data as well as data encryption, they added.

☆ China to set up new financial regulator in sweeping reform
▼ + stars: | 2023-03-07 | by ( ) www.reuters.com time to read: +6 min

The new financial regulator will replace the China Banking and Insurance Regulatory Commission (CBIRC) and bring supervision of the industry, excluding the securities sector, into a body directly under the State Council, or cabinet. The proposal for setting up the new regulator, the National Financial Regulatory Administration, was presented to China's parliament during its annual meeting on Tuesday. China's financial sector is overseen by the People's Bank of China (PBOC), the CBIRC, and the China Securities Regulatory Commission (CSRC), with the cabinet's Financial Stability and Development Committee having overall responsibility. The setting up of the new financial regulatory body comes as Beijing seeks to rein in large corporate and financial institutions that may bring systemic risks via regulatory arbitrage among multiple authorities. 'STRENGTHEN SUPERVISION'The new administration will "strengthen institutional supervision, supervision of behaviours and supervision of functions", according to the plan.

☆ China to form a national bureau to manage its troves of data
▼ + stars: | 2023-03-07 | by ( ) www.reuters.com time to read: +2 min

SHANGHAI, March 7 (Reuters) - China will form a national data bureau that will be responsible for coordinating the sharing and development of the country's data resources, according to a plan submitted on Tuesday to parliament. The proposed bureau will be administrated by the state planning agency, the National Development and Reform Commission (NDRC), the plan said. This has included issuing a series of new laws that require organisations with large user bases undergo assessments and obtain approvals when handling data. Some firms are struggling with a deadline requiring them to seek approval to export user data. "Multinationals will no doubt want to understand how a centralised data regulator will interface with overseas stakeholders."

Previously the Communist Party chief in Shanghai, Li is poised to be confirmed as premier on Saturday during the ongoing National People's Congress, charged with managing the world's second largest economy. Trey McArver, co-founder of consultancy Trivium China, said Li is likely to be much more powerful than his predecessor. "Officials know that Li Qiang is Xi Jinping's guy," he said. "He clearly thinks that Li Qiang is a very competent person and he has put him in this position because he trusts him and he expects a lot of him." American author Robert Lawrence Kuhn, who met Li and Xi together in 2005 and 2006, said the two shared an easy rapport.

☆ Asian stocks gain as prospects of China recovery, and Fed caution
▼ + stars: | 2023-03-03 | by ( Julie Zhu | ) www.reuters.com time to read: +4 min

HONG KONG, March 3 (Reuters) - Asian shares rose on Friday on prospects for a steady economic recovery in China, and after Wall Street reversed losses overnight following remarks by the Atlanta Federal Reserve chief that signalled a measured approach raising U.S. interest rates. Global markets have been buffeted by a raft of strong U.S. data over recent weeks, including U.S. jobless claims overnight, that suggested the Fed would need to keep rates higher for longer. MSCI's broadest index of Asia-Pacific shares outside Japan (.MIAPJ0000PUS) was up 0.7%, on track for its first weekly rise in five. U.S. stocks rose on Thursday, reversing earlier losses, as Treasury yields pulled back from earlier highs, following the rates comments from Atlanta Fed President Bostic. The two-year yield , which rises with traders' expectations of higher Fed fund rates, rose to 4.8879%compared with a U.S. close of 4.904%.

REUTERS/Tingshu WangHONG KONG/BEIJING/SHANGHAI, March 3 (Reuters) - As unprecedented protests against China's zero-COVID policies escalated in November, Li Qiang, the man recently elevated to No.2 on the ruling Communist Party's Politburo Standing Committee, seized the moment. Meanwhile, some local-level party workers and healthcare officials were grappling with growing challenges in implementing the zero-COVID policy. "From my perspective, it's not that we set out to relax the zero-COVID policy, it's more that we at the local level were simply not able to enforce the zero-COVID policy anymore," the official said. In mid-November, when Xi was still in Southeast Asia, he ordered Chinese authorities to "unswervingly" execute the zero-COVID policy, said two of the people, after which some cities retightened curbs. Xi's vacillating led to renewed debate on COVID policy among top leaders during mid to late November, one of these people and another person said.

☆ Asian stocks up on hopes Fed will adopt slow approach to more hikes
▼ + stars: | 2023-03-03 | by ( Julie Zhu | ) www.reuters.com time to read: +3 min

HONG KONG, March 3 (Reuters) - Asian shares rose on Friday after Wall Street reversed losses on signals of a measured policy tightening approach from the U.S. Federal Reserve as well as on prospects of a solid economic recovery in China. Australian shares (.AXJO) were up 0.36%, helped by gains in miners and financials, while Japan's Nikkei stock index (.N225) rose 1.42%. U.S. stocks rose on Thursday, reversing earlier losses, as Treasury yields pulled back from earlier highs, following the rates comments from Atlanta Fed President Bostic. read moreThe yield on benchmark 10-year Treasury notes touched 4.0556% compared with its U.S. close of 4.073% on Thursday. The two-year yield , which rises with traders' expectations of higher Fed fund rates, rose to 4.8913%compared with a U.S. close of 4.904%.

HONG KONG, March 3 (Reuters) - Bank of America (BAC.N) and Citigroup (C.N) have cut some investment banking jobs in Asia, people familiar with the matter told Reuters, joining global peers in paring headcount as China dealmaking slows. Citi on Thursday trimmed four jobs from its China investment banking team, said one of the two people and a separate person. BofA and Citi both declined to comment on layoffs involving investment bankers in Asia. JPMorgan (JPM.N) has also cut around 20 investment banking jobs, mostly mid-level bankers focused on China deals, according to two separate sources. Nomura Holdings Inc (8604.T) has cut 18 Asian banking jobs, most of them China-focused investment banking roles, sources have said.

Though the reasons for Bao's disappearance are unclear, his case follows a series of incidents in which high-profile executives in China have gone missing with little explanation during a sweeping anti-corruption campaign spearheaded by President Xi Jinping. China Renaissance said on Thursday in a stock exchange filing that it had no information that Bao's "unavailability" was related to its business, and that its operations were continuing normally. A spokesperson for Beijing-based China Renaissance declined to comment on specific details and referred Reuters to its exchange filing made on Thursday. "What happened to China Renaissance highlighted the key man risk with some Chinese companies," Li Nan, professor of Finance at Shanghai Jiaotong University, said. key man risk generally refers to the threat posed to a company from over-reliance on a limited number of personnel for decision making.

Warburg has approached a number of Chinese investors including local government-backed entities and state-backed financial institutions for the new yuan fund, the people with knowledge of the matter said. The U.S. private equity (PE) firm plans to primarily focus on the healthcare and industrial technology sectors in China with the yuan fund, one of the people said. "RMB (yuan) funds are relatively independent and self-sustainable," he said. Sensitive sectors will remain closed to global private equity groups even if they raise yuan funds, she added. Emerging markets-focused Affirma Capital is also targeting a 2 billion yuan raising in its debut fund and reached first close at 1.5 billion yuan by end-2022, a person close to the situation said.

Feb 17 (Reuters) - Chinese dealmaker Bao Fan, founder of investment bank China Renaissance Holdings Ltd (1911.HK), has gone missing in the latest disappearance of a top business executive, unnerving investors and sending its stock down as much as 50% on Friday. A China Renaissance spokesperson referred Reuters request for comment on Friday to the investment bank's public filing. The firm earned $20.6 million in Chinese related investment banking fees in 2022, down from $43.13 million a year earlier, the data showed. Bao started China Renaissance in 2005 as a two-person team, seeking to match capital-hungry startups with venture capitalist and private equity investors. China Renaissance is also an active investor in the tech sector.

☆ In COVID China, a hospital bed can hinge on who you know, red packets
▼ + stars: | 2023-02-14 | by ( Engen Tham | ) www.reuters.com time to read: +6 min

After hours of frantic calls, Steven was taken to a packed hospital and given oxygen and a bed in a children’s ward. If you know the head of the hospital, then there won’t be trouble getting a bed," a Shanghai doctor said. Although China has tried to crack down on doctor bribery, the regulatory focus has been on payments from pharmaceutical companies rather than patients. Doctors and experts said the use of red packets and "guanxi", or connections, to gain access persists. "Many of those rural patients, COVID patients, that had severe symptoms would choose not to proactively seek care; instead they just die at home," Huang said.

Interest rate announcements are also due on Thursday from the Bank of England and the European Central Bank - and both are expected to hike rates by 50 bps. Equity markets may have factored in the end of central bank rate hikes, but they do not yet reflect the potential hit to earnings from a slowing economy, Schneller said. U.S. stock futures, the S&P 500 e-minis , were down 0.3%. read moreU.S. stock futures fell, pointing to a lower open for the benchmark indices following Monday's losses. U.S. Treasury yields edged lower ahead of the central bank meetings and economic data, with the benchmark 10-year note last down 3 basis points at 3.524% .

☆ Asian stocks edge down as investors eye central bank hikes
▼ + stars: | 2023-01-31 | by ( Julie Zhu | ) www.reuters.com time to read: +4 min

Interest rate announcements are due on Thursday from both the Bank of England and the European Central Bank - and both are expected to hike rates by 50 bps. U.S. stock futures, the S&P 500 e-minis , were down 0.06%. The Dow Jones Industrial Average (.DJI) fell 0.8% to 33,717.09, the S&P 500 (.SPX) lost 1.3% to 4,017.77 and the Nasdaq Composite (.IXIC) dropped 2.0% to 11,393.81. Despite Monday's declines, the S&P 500 remained on track to post its biggest January gain since 2019. In the energy market, oil prices fell ahead of the expected hikes by central banks and signals of strong Russian exports.

☆ Asian stocks slip as investors eye central bank hikes
▼ + stars: | 2023-01-31 | by ( Julie Zhu | ) www.reuters.com time to read: +3 min

Jan 31 (Reuters) - Asian shares traded cautiously and bonds nursed small losses on Tuesday as investors braced for an eventful week that includes central bank meetings, a slew of earnings reports and key U.S. economic data. Rate announcements are due on Thursday from both the Bank of England and the European Central Bank - and both are expected to hike rates by 50 bps. U.S. stock futures, the S&P 500 e-minis , rose 0.1%. The Dow Jones Industrial Average (.DJI) fell 0.8% to 33,717.09, the S&P 500 (.SPX) lost 1.3% to 4,017.77 and the Nasdaq Composite (.IXIC) dropped 2.0% to 11,393.81. Despite Monday's declines, the S&P 500 remained on track to post its biggest January gain since 2019.

☆ Didi's China ride-hailing app back on some app stores
▼ + stars: | 2023-01-17 | by ( ) www.reuters.com time to read: +1 min

BEIJING, Jan 17 (Reuters) - Didi Global's Chinese ride-hailing app returned to some Android app stores on Tuesday, according to Reuters checks and a source with direct knowledge of the matter, signalling its emergence from around 1-1/2 years of regulatory troubles. Didi has been awaiting approval to resume new user registrations and downloads of its 25 banned apps in China as a key step to return to normal business since its regulatory problems started in mid-2021. Its 25 mobile apps were then ordered to be taken down from app stores, the registration of new users was suspended, and it was fined $1.2 billion over data-security breaches. Didi said in a statement on Monday it had been given the green light from domestic regulators to resume new user registrations for its core ride-hailing app from Monday. Reporting by Yingzhi Yang and Julie Zhu Editing by David Goodman and Mark PotterOur Standards: The Thomson Reuters Trust Principles.

☆ China lifts ban on ride-hailing giant Didi's new user registration -company statement
▼ + stars: | 2023-01-16 | by ( ) www.reuters.com time to read: +1 min

Jan 16 (Reuters) - China's ride hailing giant Didi Global said in a statement on Monday it would be allowed to resume new user registration, after a more than year-long ban that curbed its growth. The company would take effective measures to ensure platform safety and data security, and safeguard national cyberspace security, it said in the statement. Didi has been awaiting approval to resume new user registrations and downloads of its 25 banned apps in China as a key step to a return to normal business since its regulatory troubles started in mid-2021. Didi will need its ride-hailing and other apps to be back on domestic app stores to win new users, though the statement did not specifically mention it. Reporting by Yingzhi Yang and Julie Zhu; Editing by Kim Coghill and Tom HogueOur Standards: The Thomson Reuters Trust Principles.

[1/2] The app logo of Chinese ride-hailing giant Didi is seen reflected on its navigation map displayed on a mobile phone in this illustration picture taken July 1, 2021. Didi has been awaiting authorities' approval to resume new user registrations and downloads of its 25 banned apps in China as a key step to resume normal business since its regulatory troubles started in mid-2021. A lifting of the ban on Didi apps would come as Chinese policymakers seek to restore private sector confidence and count on the technology industry to help spur economic activity that has been ravaged by the COVID-19 pandemic. The delay in the return of the apps had cast a shadow over Didi's business plans. That deal is primarily subject to the apps' resumption for official announcement, said the two sources.

☆ China's 'great migration' kicks-off under shadow of COVID
▼ + stars: | 2023-01-07 | by ( Casey Hall | ) www.reuters.com time to read: +6 min

BORDER REOPENINGSunday marks the reopening of China's border with Hong Kong and the end of China's requirement for inbound international travellers to quarantine. More than a dozen countries are now demanding COVID tests from Chinese travellers, as the World Health Organisation said China's official virus data underreported the true extent of its outbreak. In Shanghai, for example, the city government on Friday announced an end to free PCR tests for residents from Jan. 8. China has relied on nine domestically-developed COVID vaccines approved for use, including inactivated vaccines, but none have been adapted to target the highly-transmissible Omicron variant and its offshoots currently in circulation. China reported three new COVID deaths in the mainland for Friday, bringing its official virus death toll to 5,267, one of the lowest in the world.

HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc (PFE.N) to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in China, three sources told Reuters. In February last year, China approved Paxlovid, which was supposed to be largely available via hospitals, to treat high-risk patients in several provinces. Pfizer last month reached an agreement to export Paxlovid to China through a local company to make the medicine more widely available. A Pfizer spokesperson said the company is actively collaborating with Chinese authorities and all stakeholders to secure an adequate supply of Paxlovid in China. That licence does not allow the companies to sell generic Paxlovid in China.

The country spent big on quarantine and testing facilities over the past three years rather than bolstering hospitals and clinics and training medical staff, these people said. "There is no transition time for the medical system to prepare for this," said Zuofeng Zhang, professor of epidemiology at the University of California, Los Angeles. The failure to boost vaccination rates among the vulnerable could imperil China's health system, more than a dozen experts said. The death of a 23-year-old medical student in Chengdu on Dec. 14 fueled public ire at the strain on China's health system. Chen Jiming, a researcher at China's Foshan University, said there was every chance that China's medical system could cope now that the country has ended quarantine for asymptomatic and mild cases.

"For whole of Beijing, speedy arrangement of hearses, no queue for cremation," the worker said in a plug for service on the popular short video app Douyin. The fee being charged exceeds all-in-one funeral service packages advertised in the city. China, which uses a narrow definition for classifying COVID fatalities, reported no new COVID deaths for Dec. 20, compared with five the previous day. Authorities clarified on Tuesday that only deaths caused by pneumonia and respiratory failure after contracting COVID will be classified as COVID deaths. The Beijing municipal government and National Health Commission did not immediately respond to requests for comment about the apparent rise in deaths in Beijing.

SYDNEY/BEIJING, Dec 15 (Reuters) - The rising alarm over COVID-19 spreading in China was felt in pharmacies in Hong Kong, Macau, and in some neighbourhoods in Australia, as people hunted for fever medicines and virus test kits to send to family and friends on the mainland. Several shops have since imposed limits on how much customers can buy, and drugmakers are ramping up production. They like to hoard medicines before they even get sick," said a doctor in Shanghai. "I have friends in Beijing who asked me to send over some flu medicines and rapid tests. And the government-backed Sinopharm Group has tripled daily production capacity of key drugs, state run CCTV reported, due to a sharp increase in demand for medicines to treat fever and cough symptoms.

China's health authority did not immediately respond to a request for comment on infections among medical staff. A few nurses at the fever clinic were tested positive, there aren’t any special protective measures for hospital staff and I believe many of us will soon get infected," Li added. A post on the Weibo social media platform recounted a recent experience at the emergency ward at Beijing Hospital. "Those who have not been to the emergency department of Beijing Hospital don't know what a mess it has become," wrote a Weibo user called Moshang. Beijing Hospital did not immediately respond to a Reuters' request for comment.

That compares with a valuation of about $9 billion in its maiden external fundraising last year. In doing so, it joins a growing list of Chinese automakers looking to launch or expand sales of EVs in the region. The automotive group led by founder Li Shufu now houses seven brands manufacturing electric vehicles, of which three are high-end brands. According to two of the sources, Zeekr also considered Hong Kong as its listing venue but picked New York in the hope of achieving a higher valuation. Zeekr was established by Geely, formally known as Zhejiang Geely Holding Group (GEELY.UL), in April 2021 to tap into increasing Chinese demand for premium EVs.

Search resuls for: "Julie Zhu"

25 mentions found